Lead identification in post-genomics: Computers as a complementary alternative

Drug Discovery Today: Technologies

Volumn 1, Issue 3, 2004, Pages 225-230

  Klebe, Gerhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; CARBONATE DEHYDRATASE II; CASEIN KINASE II; DRUG; EPITOPE; GLYCOSYLTRANSFERASE; INTEGRIN RECEPTOR; LIGAND; PROTEIN; PROTEIN TYROSINE PHOSPHATASE 1B; THERMOLYSIN; THYROID HORMONE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UROTENSIN II; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; COMPLEX FORMATION; COMPUTER AIDED DESIGN; COMPUTER SYSTEM; DNA TEMPLATE; DRUG IDENTIFICATION; DRUG SCREENING; EXPOSURE; GENOMICS; HIGH THROUGHPUT SCREENING; INFORMATION PROCESSING; MOLECULAR LIBRARY; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN FAMILY; VIRTUAL REALITY;

EID: 13344279324     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2004.10.010     Document Type: Review

References (20)

1. A. Good Structure-based virtual screening protocols Curr. Opin. Drug Discov. Dev. 4 2001 301-307
2. B. Waszkowycz Structure-based approaches to drug design and virtual screening Curr. Opin. Drug Discov. Dev. 5 2002 407-413
3. C.S. Ramesha How many leads from HTS? Comment Drug Discov. Today 5 2000 43-44
4. R. Lahana How many leads from HTS? Drug Discov. Today 4 1999 447-448
5. D.A. Erlanson et al. Fragment-based drug discovery J. Med. Chem. 47 2004 3465-3482
6. H. Gohlke G. Klebe Approaches to the description and prediction of binding affinity of small-molecule ligands to macromolecular receptors (Ansätze zur Vorhersage und Beschreibung der Bindungsaffinität niedermolekularer Liganden an makromolekulare Rezeptoren) Angew. Chem. Int. Ed. Engl. 41 2002 2644-2676
7. H. Gohlke G. Klebe Statistical potentials and scoring functions applied to protein-ligand binding Curr. Opin. Struct. Biol. 11 2001 231-235
8. S. Grüneberg et al. Successful virtual screening for novel inhibitors of human carbonic anhydrase: Strategy and experimental confirmation J. Med. Chem. 45 2002 3588-3602
9. R. Brenk et al. Virtual screening for submicromolar leads of TGT based on a new unexpected binding mode detected by crystal structure analysis J. Med. Chem. 46 2003 1133-1143
10. R. Brenk et al. Crystallographic study of inhibitors of tRNA-guanine transglycosylase suggests a new structure-based pharmacophore for virtual screening J. Mol. Biol. 338 2004 55-75
11. O. Krämer et al. Virtual screening for inhibitors of human aldose reductase Proteins Struct. Funct. Genet. 55 2004 814-823
12. Evers, A., Klebe, G. (2004) Ligand-supported homology modelling of G-protein coupled receptor sites: Models sufficient for successful virtual screening. Angew. Chem. Int. Ed. 43 248-251
13. Evers A. Klebe G. Angew. Chem. 116 250-253
14. P. Ferrara et al. Assessing scoring functions for protein-ligand interactions J. Med. Chem. 47 2004 3032-3047
15. R. Wang et al. Comparative evaluation of 11 scoring functions for molecular docking J. Med. Chem. 46 2003 2287-2303
16. H. Gohlke G. Klebe DrugScore meets CoMFA: Adaptation of fields for molecular comparison (AFMoC) or how to tailor knowledge-based pair-potentials to a particular protein J. Med. Chem. 45 2002 4153-4170
17. M. Hendlich et al. Design and development of relibase - a database for comprehensive analysis of protein-ligand interactions J. Mol. Biol. 326 2003 607-620
18. J. Günther et al. Utilising structural knowledge in drug design strategies - applications using relibase J. Mol. Biol. 326 2003 621-636
19. F. Dullweber et al. Factorising ligand affinity: A combined thermodynamic and crystallographic study of trypsin and thrombin inhibition J. Mol. Biol. 313 2001 593-614
20. S. Schmitt et al. A new method to detect related function among proteins independent of sequence and fold homology J. Mol. Biol. 323 2002 387-406